Valuation (38%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.20 | 25.58 |
PEG Ratio (TTM) | 0.01 | -26.08 |
P/S Ratio (TTM) | 0.03 | 2.28 |
P/B Ratio (TTM) | 0.19 | 45.41 |
P/FCF Ratio (TTM) | -0.61 | 23.43 |
Price to 5YR AVG Earnings Ratio | N/A | 27.89 |
Price to 5YR AVG FCF Ratio | N/A | 25.71 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -23.30% | 14.75% |
ROE (TTM) | -72.84% | 306.92% |
Net Profit Margin (TTM) | -14.30% | 8.95% |
ROIC 5YR AVG | N/A | 45.87% |
Growth (27%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -67.09% | 121.64% | N/A |
Revenue | -5.84% | 0.61% | N/A |
Net Income | -68.00% | 124.87% | N/A |
Cash Flow | -132.84% | 15,719.05% | N/A |
Health (32%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.55 | 1.14 |
Quick Ratio (TTM) | 0.13 | 0.29 |
D/E Ratio (TTM) | 0.94 | 6.23 |
Interest Coverage (TTM) | N/A | 10.40 |
Piotroski F-Score | 3 | 6 |
Altman Z-Score | 1.35 | 5.47 |
LTL to 5YR AVG FCF | N/A | 22.89 |
Shares Outstanding Growth 5YR AVG | N/A | -3.44% |